Dark

Check out our Level2View

POAI
Predictive Oncology Inc. Common Stock
stock NASDAQ

Inactive

Dec 11, 2025

5.95USD+0.507%(+0.03)52,548

Pre-market

0.00USD-100.000%(-5.92)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 27, 2022

07:30AM EST Predictive Oncology set to market AI drug discovery platform GlobeNewswire Inc

Jan 13, 2022

11:47AM EST Predictive Oncology Reports Prelim. Results Of Its Discovery 2021 Program: Its Helomics Unit Showed Proprietary AI Porogram CoRE Could Identify Potential New Chemo Drug Uses Benzinga

08:30AM EST POAI Reports Strong Results From Its AI Cancer Drug GlobeNewswire Inc

Dec 27, 2021

05:10PM EST Predictive Oncology Adjourns Annual Meeting of Stockholders to GlobeNewswire Inc

Dec 21, 2021

08:30AM EST PredictiveOncology, (POAI), a knowledge-driven company focused on applying artificial intelligence (AI) to develop personalized cancer therapies, is moving in the right direction. GlobeNewswire Inc

Dec 7, 2021

08:30AM EST Pamela Bush, Ph.D., MBA, Joins Predictive Oncology as SVP of GlobeNewswire Inc

Dec 1, 2021

08:33AM EST Predictive Oncology Acquires zPREDICTA; Terms Not Disclosed Benzinga

08:30AM EST Predictive Oncology Acquires zPREDICTA, Inc. GlobeNewswire Inc

Nov 10, 2021

06:44PM EST Predictive Oncology Q3 EPS $(0.08) Up From $(0.46) YoY, Sales $313.66K Down From $480.76K YoY Benzinga

Oct 19, 2021

08:30AM EDT Predictive Oncology, an oncology and cancer research company using big data and machine learning to improve pharmaceutical development and predictive treatment outcomes, launched a website today that emphasizes its role in advancing its mission. GlobeNewswire Inc

Sep 15, 2021

08:30AM EDT Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (AI) to personalized medicine and drug discovery, is excited to announce that Raymond F. Vennare was elected to the Board of Directors, pursuant to action of the Board effective September 13, 2021. GlobeNewswire Inc

Aug 18, 2021

01:46PM EDT Predictive Oncology Announces Results of Charter Amendment Proposal at Special Meeting; Shareholders Approved Amendment To Increase Number Of Authorized Shares From 100M To 200M, Effective Aug. 17, 2021 Benzinga

01:45PM EDT Predictive Oncology Announces Results of Charter Amendment GlobeNewswire Inc

Aug 11, 2021

05:17PM EDT Predictive Oncology Q2 EPS $(0.05) Up From $(0.36) YoY Benzinga

08:30AM EDT Predictive Oncology Adjourns Special Meeting of Stockholders GlobeNewswire Inc

Aug 3, 2021

08:30AM EDT Predictive Oncology subsidiary, Helomics uses data from the GlobeNewswire Inc

Jun 30, 2021

10:56AM EDT Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2021 Benzinga

06:24AM EDT HC Wainwright & Co. Initiates Coverage On Predictive Oncology with Buy Rating, Announces Price Target of $5 Benzinga

Jun 22, 2021

08:34AM EDT Predictive Oncology Says Subsidiaries Soluable Biotech, TumorGenesis Both Constructing New GMP Labs Benzinga

08:30AM EDT Predictive Oncology (NASDAQ: POAI), an AI-driven oncology and drug discovery company, announced today that two of their wholly owned subsidiaries, Soluble Biotech Inc. and TumorGenesis Inc. are both expanding their unique services by completing the fabrication and qualification of GMP facilities. GlobeNewswire Inc

Jun 18, 2021

09:30AM EDT Predictive Oncology Announces Closing of $21.34 Million Registered GlobeNewswire Inc

Jun 14, 2021

09:30AM EDT Predictive Oncology Announces $21.34 Million Registered Direct GlobeNewswire Inc

Jun 2, 2021

08:30AM EDT Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (AI) to personalized medicine and drug discovery, announced today that its three wholly owned subsidiaries, Helomics, TumorGenesis and Soluble Biotech, will be attending BIO DIGITAL, a key international biotech partnering event held virtually on June 10-11 & 14-18, 2021. GlobeNewswire Inc

May 20, 2021

08:30AM EDT Predictive Oncology Inc.s Wholly Owned GlobeNewswire Inc

May 12, 2021

05:57PM EDT Predictive Oncology Q1 EPS $(0.11) Up From $(0.93) YoY, Sales $280.32K Up From $294.94K YoY Benzinga

05:20PM EDT Predictive Oncology Inc. (Nasdaq: POAI),a knowledge-driven company focused on applying artificial intelligence (AI) to personalized medicine and drug discovery, today reported financial results for the quarter ended March 31, 2021 and provided an update on business activities. GlobeNewswire Inc

Apr 28, 2021

05:28PM EDT Predictive Oncology Files For Mixed Shelf Of Up To $250M Benzinga

Apr 27, 2021

08:30AM EDT Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (AI) to personalized medicine and drug discovery, is excited to announce today their newest Board Member Dr. Christina Jenkins. GlobeNewswire Inc

Apr 21, 2021

08:37AM EDT (via InvestorWire) InvestorBrandNetwork(IBN), a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode ofThe Bell2Bell Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. GlobeNewswire Inc

Mar 23, 2021

03:35PM EDT Traders Circulate Recent US Patent & Trademark Office Abstract For Predictive Oncology dba Skyline Medical 'Fluid waste collection and disposal system and method' Benzinga

08:33AM EDT Predictive Oncology Appoints J. Melville Engle As CEO Benzinga

08:30AM EDT Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence to personalized medicine and drug discovery, is excited to announce today that they have appointed J. Melville (Mel) Engle as Chief Executive Officer of the company. GlobeNewswire Inc

Mar 16, 2021

08:17AM EDT The Daily Biotech Pulse: Fulgent Nabs CDC Contract, Enzo Rallies, Solid Biosciences Releases Gene Therapy Data, Moderna Begins Pediatric Vaccine Study Benzinga

Mar 15, 2021

05:15PM EDT Predictive Oncology (NASDAQ: POAI) Predictive Oncology (Nasdaq: POAI),a knowledge-driven company focused on applying artificial intelligence (AI) to personalized medicine and drug discovery, today reported financial results for the year ended December 31, 2020 and provided an update on business activities. GlobeNewswire Inc

Mar 8, 2021

08:47AM EST Predictive Oncologys, Skyline Medical Division, GlobeNewswire Inc

08:44AM EST Predictive Oncology Says Co's Skyline Medical Division Developing Generation 3 Direct-To-Drain Automated Fluid Waste Management System Benzinga

Feb 24, 2021

08:31AM EST Predictive Oncology's Helomics Division Announces Progress On Milestones For Its AI-Driven Model Of Ovarian Cancer Benzinga

08:30AM EST POAI s Helomics Division Announces Progress on GlobeNewswire Inc

Feb 23, 2021

05:30PM EST Predictive Oncology Announces Closing of $17.6 Million Private GlobeNewswire Inc

Feb 18, 2021

09:18AM EST Predictive Oncology Prices 9,043,766 Share Common Stock Offering At $1.95/Share Benzinga

09:00AM EST Predictive Oncology Announces $17.6 Million Private Placement GlobeNewswire Inc

Feb 17, 2021

08:35AM EST Predictive Oncology Highlights Use Of Products From Its TumorGenesis Subsidiary By Researches In Ovarian Cancer Benzinga

08:30AM EST Two Top Researchers find Breakthrough Discoveries using Predictive GlobeNewswire Inc

Feb 16, 2021

05:00PM EST Predictive Oncology Announces Closing of $7.4 Million Registered GlobeNewswire Inc

Feb 11, 2021

12:30AM EST Predictive Oncology Announces $7.4 Million Registered Direct GlobeNewswire Inc

Feb 8, 2021

08:37AM EST Predictive Oncology's Wholly Owned Subsidiary Helomics Announces The Start Of Its Drug Repurposing Project Using Its PeDAL Platform For Ovarian Cancer Benzinga

08:30AM EST Predictive Oncologys Wholly Owned Subsidiary GlobeNewswire Inc

Feb 2, 2021

12:03PM EST Predictive Oncology Says Has Regained Compliance With Nasdaq Minimum Bid Price Requirement Benzinga

12:00PM EST Predictive Oncology Has Regained Compliance with GlobeNewswire Inc

08:30AM EST Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (AI) to personalized medicine and drug discovery, announced today that equity research firm,Litchfield Hills Research LLC, released its first analyst coverage report on (Nasdaq: POAI), rating the Company a "Buy" under its three-tiered (buy-hold-sell) rating system. GlobeNewswire Inc

Jan 28, 2021

08:41AM EST Predictive Oncology Subsidiary Inks Contract With A Pharmaceutical Company RTTNews

08:36AM EST Predictive Oncology Subsidiary Soluble Biotech Announces Contract With Pharmaceutical Company To 'improve the solubility and stability of a protein therapeutic destined for future clinical use' Benzinga

08:30AM EST Soluble Biotech, a Wholly Owned Subsidiary of Predictive Oncology, GlobeNewswire Inc

Jan 26, 2021

09:00PM EST Predictive Oncology Announces Closing of $4.1 Million Registered GlobeNewswire Inc

Jan 22, 2021

08:02AM EST Predictive Oncoloy Prices 3.4M Share Offering At $1.20/Share Benzinga

08:00AM EST Predictive Oncology Announces $4.1 Million Registered Direct GlobeNewswire Inc

Jan 21, 2021

05:25PM EST Predictive Oncology Announces Closing of $2.2 Million Registered GlobeNewswire Inc

Jan 19, 2021

08:07AM EST Predictive Oncology Announces $2.2M Registered Direct Offering Priced At-The-Market Benzinga

08:00AM EST Predictive Oncology Announces $2.2 Million Registered Direct GlobeNewswire Inc

Jan 14, 2021

08:35AM EST Predictive Oncology Subsidiary, TumorGenesis, Sells Media To Two Top Research Medical Centers RTTNews

08:33AM EST Predictive Oncology Reports Wholly Owned Subsidiary TumorGenesis Has Sold Media To Two Top Research Medical Centers Benzinga

08:30AM EST Predictive Oncology Reports That Its Wholly Owned Subsidiary, GlobeNewswire Inc

Jan 12, 2021

05:15PM EST Predictive Oncology Announces Closing of $3.074 Million Registered GlobeNewswire Inc

Jan 8, 2021

09:03AM EST Predictive Oncology Announces $3,074,007 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules Benzinga

09:00AM EST Predictive Oncology Announces $3,074,007 Registered Direct GlobeNewswire Inc

Jan 6, 2021

08:30AM EST Predictive Oncologys Wholly Owned Subsidiary GlobeNewswire Inc

Jan 5, 2021

08:30AM EST Predictive Oncology Hires Investor Relations Firm GlobeNewswire Inc

Dec 29, 2020

05:16PM EST Predictive Oncology Announces Cancellation of Special Meeting in December 2020 Benzinga

05:15PM EST Predictive Oncology Announces Cancellation of Special Meeting in GlobeNewswire Inc

Dec 9, 2020

08:35AM EST Predictive Oncology Sends Letter To Shareholders Regarding Special Meeting To Be Reconvened On December 30, 2020 Benzinga

08:30AM EST Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (AI) to personalized medicine and drug discovery, today sent a letter to shareholders regarding its virtual Special Meeting of Stockholders, original scheduled for December 1, 2020, which will be reconvened December 30, 2020 at 3 p.m. CST. GlobeNewswire Inc

Dec 2, 2020

08:00AM EST Predictive Oncology Announces Adjournment of Special Meeting GlobeNewswire Inc

Nov 16, 2020

05:24PM EST Predictive Oncology Q3 EPS $(0.46) Up From $(1.31) YoY, Sales $480.76K Down From $522.70K YoY Benzinga

05:20PM EST Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (AI) to personalized medicine and drug discovery, today reported financial results for the quarter ended September 30, 2020 and provided a business update. GlobeNewswire Inc

Nov 6, 2020

07:47AM EST The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold Benzinga

Oct 30, 2020

08:09AM EDT The Daily Biotech Pulse: Novavax Vaccine Data, Axovant Flags Delay In Parkinson's Study, 2 Biotechs Make Wall Street Debuts Benzinga

Oct 29, 2020

07:30AM EDT The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal Benzinga

Oct 27, 2020

08:31AM EDT Predictive Oncology CEO Provides Updates On Subsidiaries, Highlights Recent Milestones, Near-Term Goals Benzinga

08:30AM EDT Predictive Oncology Inc. CEO Provides Updates on Subsidiaries, GlobeNewswire Inc

Oct 13, 2020

01:29PM EDT Predictive Oncology CEO Schwartz Pens Letter To Shareholders, Says Revenue Is On Upward Trend, Company Has Access To Over $10 Million In Undrawn Equity Lines Of Credit Benzinga

Oct 6, 2020

08:33AM EDT Predictive Oncology CEO Letter To Shareholders; Comments On Decline Of Stock Price; Says 'Our Cash Burn Is Stable And Trending Downward' Benzinga

08:33AM EDT Predictive Oncology CEO Letter To Shareholders Benzinga

08:30AM EDT Predictive Oncology (NASDAQ:POAI), a knowledge-driven company focused on applying artificial intelligence (AI) to personalized medicine and drug discovery, is pleased to release the CEOs letter to the shareholders. GlobeNewswire Inc

Sep 22, 2020

05:11PM EDT Predictive Oncology Secures License For An Additional 71 Unique Ovarian Cancer Cell Lines From Ximbio Benzinga

05:10PM EDT Predictive Oncology Secures License for an Additional 71 Unique GlobeNewswire Inc

Sep 1, 2020

05:15PM EDT Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (AI) to personalized medicine and drug discovery, today announced that management, will present at the LD Micro's "LD 500" Virtual Investor Conference, on Wednesday, September 02, 2020 3:40 PM Eastern Time. GlobeNewswire Inc

Aug 20, 2020

08:35AM EDT Predictive Oncology Says Soluble Biotech Division Just Received Its First Substantial Contract RTTNews

08:30AM EDT Soluble Biotech Announces First Contract with a Major GlobeNewswire Inc

Aug 18, 2020

08:32AM EDT Predictive Oncology Reports Co's Skyline Medical Sells 8 STREAMWAY Systems To A Large University Hospital Organization In Virginia; 13 Systems Sold Halfway Into Q3 2020 Benzinga

08:30AM EDT Predictive Oncologys Skyline Medical Sells 8 GlobeNewswire Inc

Aug 14, 2020

08:30AM EDT Predictive Oncology Announces DojoLIVE! Interview with Helomics GlobeNewswire Inc

Aug 13, 2020

05:14PM EDT Predictive Oncology Q2 EPS $(0.36) Benzinga

05:10PM EDT Increases Readiness for Commercialization with Expanded Portfolio of Solutions for Precision Medicine GlobeNewswire Inc

Aug 11, 2020

08:36AM EDT Predictive Oncology Seeking Approval Of A One-Time Repricing Of All Stock Options Outstanding Under Amended And Restated 2012 Stock Incentive Plan Benzinga

08:31AM EDT Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (AI) to personalized medicine and drug discovery, today issued a letter to shareholders discussing the Companys recent accomplishments and voting recommendations from its Board of Directors for two proposals that are scheduled for shareholder vote on September 3, 2020. GlobeNewswire Inc

Jul 14, 2020

08:30AM EDT Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (AI) to personalized medicine and drug discovery, today announced the appointment of three new members to the companys board of directors, effective immediately. GlobeNewswire Inc

Share